NLRP3 inflammasome in cognitive impairment and pharmacological properties of its inhibitors

Yi Xu,Yanling Yang,Xi Chen,Danling Jiang,Fei Zhang,Yao Guo,Bin Hu,Guohai Xu,Shengliang Peng,Lidong Wu,Jialing Hu
DOI: https://doi.org/10.1186/s40035-023-00381-x
2023-11-02
Translational Neurodegeneration
Abstract:Abstract Cognitive impairment is a multifactorial and multi-step pathological process that places a heavy burden on patients and the society. Neuroinflammation is one of the main factors leading to cognitive impairment. The inflammasomes are multi-protein complexes that respond to various microorganisms and endogenous danger signals, helping to initiate innate protective responses in inflammatory diseases. NLRP3 inflammasomes produce proinflammatory cytokines (interleukin IL-1β and IL-18) by activating caspase-1. In this review, we comprehensively describe the structure and functions of the NLRP3 inflammasome. We also explore the intrinsic relationship between the NLRP3 inflammasome and cognitive impairment, which involves immune cell activation, cell apoptosis, oxidative stress, mitochondrial autophagy, and neuroinflammation. Finally, we describe NLRP3 inflammasome antagonists as targeted therapies to improve cognitive impairment.
neurosciences
What problem does this paper attempt to address?